You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Litigation Details for Purdue Pharma L.P. v. Mylan Pharmaceuticals Inc. (D. Del. 2015)

✉ Email this page to a colleague

« Back to Dashboard

Purdue Pharma L.P. v. Mylan Pharmaceuticals Inc. (D. Del. 2015)

Docket	⤷ Sign Up	Date Filed	2015-12-16
Court	District Court, D. Delaware	Date Terminated	2017-09-18
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	None	Referred To	Sherry R. Fallon
Parties	PURDUE PHARMA L.P.
Patents	7,674,799; 7,674,800; 7,683,072; 9,073,933; 9,522,919
Attorneys	Megan C. Haney
Firms	Morris, Nichols, Arsht & Tunnell
Link to Docket	External link to docket

Small Molecule Drugs cited in Purdue Pharma L.P. v. Mylan Pharmaceuticals Inc.

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up and ⤷ Sign Up .

Details for Purdue Pharma L.P. v. Mylan Pharmaceuticals Inc. (D. Del. 2015)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2017-07-12	103		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,073,933; 9,522,919; . (Smith… 18 September 2017 1:15-cv-01155 830 Patent None District Court, D. Delaware	External link to document
2017-09-19	132		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,073,933; 9,522,919. (Attachments… 18 September 2017 1:15-cv-01155 830 Patent None District Court, D. Delaware	External link to document
2016-04-22	28		for infringement of the low-ABUK patents (U.S. Patent Nos. 7,674,799, 7,674,800, and 7,683,072). The…’s U.S. Patent No. 9,073,933 (“the ’933 patent”) expires. (D.I. 1 at ¶ 32.) The ’933 patent is the only…799 patent, claims 30-34 and 76-79 of the ’800 patent, and claims 1, 4, and 5 of the ’072 patent were…prosecution of the ’933 patent for obviousness-type double patenting over the low-ABUK patents. (Br. 9-10.) According…that the ’933 patent claims “are not patentably distinct” from the invalid low-ABUK patent claims. (Id	External link to document
2016-07-07	41		's Invalidity Contentions Regarding U.S. Patent No. 9,073,933 B2 filed by Mylan Pharmaceuticals Inc., … 18 September 2017 1:15-cv-01155 830 Patent None District Court, D. Delaware	External link to document
2016-08-30	45		's Identification of Claim Terms of U.S. Patent No. 9,073,933 B2 to be Construed filed by Mylan Pharmaceuticals… 18 September 2017 1:15-cv-01155 830 Patent None District Court, D. Delaware	External link to document
2016-09-20	47		Proposed Construction of Claim Term of U.S. Patent No. 9,073,933 B2 To Be Construed filed by Mylan Pharmaceuticals… 18 September 2017 1:15-cv-01155 830 Patent None District Court, D. Delaware	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.